Neo Ivy Capital Management Neogenomics Inc Transaction History

Neo Ivy Capital Management

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$7.06 - $13.97 $24,907 - $49,286	-3,528 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$12.15 - $35.28 $41,638 - $120,904	3,427 Added 3393.07%	3,528 $42,000
Q4 2021 Feb 15, 2022	SELL	$30.49 - $48.49 $30,246 - $48,102	-992 Reduced 90.76%	101 $3,000
Q3 2021 Nov 16, 2021	BUY	$41.66 - $52.52 $45,534 - $57,404	1,093 New	1,093 $34,000
Q1 2021 Oct 07, 2021	SELL	$41.56 - $59.88 $134,903 - $194,370	-3,246 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$36.08 - $56.47 $117,115 - $183,301	3,246 New	3,246 $175,000
Q2 2020 Aug 17, 2020	SELL	$24.21 - $31.02 $26,461 - $33,904	-1,093 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$24.21 - $31.02 $26,461 - $33,904	1,093 New	1,093 $34,000

295

125M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.89B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

Stay updated on Neo Ivy Capital Management with notifications on news.